PMD - サイケメディクス (Psychemedics Corporation)

PMDのニュース

   Is Psychemedics Corp. (PMD) A Good Stock To Buy?  2021/06/14 20:25:49 Insider Monkey
   Montana Advisors Writes Open Letter to Psychemedics  2021/06/01 18:54:00 Business Wire
MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time you have given me to discuss Psychemedics Corp. (PMD or the Company). As you know, I continue to believe that PMD shares continue to trade at a significant discount to their intrinsic value. Montana has made recommendations on ways to unlock the value of the shares, including making your balance sheet wo
   Psychemedics Corporation Shares Close the Week 24.1% Higher - Weekly Wrap  2021/01/29 22:30:00 Kwhen Finance
Psychemedics Corporation shares closed this week 24.1% higher than it did at the end of last week. The stock is currently up 33.6% year-to-date, down 26.8% over the past 12 months, and down 12.3% over the past five years. This week, the Dow Jones Industrial Average fell 3.3%, and the S&P 500 fell 3.3%. Trading Activity Shares traded as high as $7.50 and as low as $5.40 this week.Shares closed 3e+1% below its 52-week high and 9e+1% above its 52-week low.Trading volume this week was 36.5% lower than the 10-day average and 11.8% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 899.3% The company's stock price performance over the past 12 months lags the peer average by -288.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Is Psychemedics Corp. (PMD) A Good Stock To Buy?  2021/06/14 20:25:49 Insider Monkey
   Montana Advisors Writes Open Letter to Psychemedics  2021/06/01 18:54:00 Business Wire
MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time you have given me to discuss Psychemedics Corp. (PMD or the Company). As you know, I continue to believe that PMD shares continue to trade at a significant discount to their intrinsic value. Montana has made recommendations on ways to unlock the value of the shares, including making your balance sheet wo
   Psychemedics Corporation Shares Close the Week 24.1% Higher - Weekly Wrap  2021/01/29 22:30:00 Kwhen Finance
Psychemedics Corporation shares closed this week 24.1% higher than it did at the end of last week. The stock is currently up 33.6% year-to-date, down 26.8% over the past 12 months, and down 12.3% over the past five years. This week, the Dow Jones Industrial Average fell 3.3%, and the S&P 500 fell 3.3%. Trading Activity Shares traded as high as $7.50 and as low as $5.40 this week.Shares closed 3e+1% below its 52-week high and 9e+1% above its 52-week low.Trading volume this week was 36.5% lower than the 10-day average and 11.8% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 899.3% The company's stock price performance over the past 12 months lags the peer average by -288.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Montana Advisors Writes Open Letter to Psychemedics  2021/06/01 18:54:00 Business Wire
MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time you have given me to discuss Psychemedics Corp. (PMD or the Company). As you know, I continue to believe that PMD shares continue to trade at a significant discount to their intrinsic value. Montana has made recommendations on ways to unlock the value of the shares, including making your balance sheet wo
   Psychemedics Corporation Shares Close the Week 24.1% Higher - Weekly Wrap  2021/01/29 22:30:00 Kwhen Finance
Psychemedics Corporation shares closed this week 24.1% higher than it did at the end of last week. The stock is currently up 33.6% year-to-date, down 26.8% over the past 12 months, and down 12.3% over the past five years. This week, the Dow Jones Industrial Average fell 3.3%, and the S&P 500 fell 3.3%. Trading Activity Shares traded as high as $7.50 and as low as $5.40 this week.Shares closed 3e+1% below its 52-week high and 9e+1% above its 52-week low.Trading volume this week was 36.5% lower than the 10-day average and 11.8% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 899.3% The company's stock price performance over the past 12 months lags the peer average by -288.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

calendar